Entocort ec and Nasopharyngitis - a phase IV clinical study of FDA data

Summary:

Nasopharyngitis is reported as a side effect among people who take Entocort ec (budesonide), especially for people who are female, 30-39 old, have been taking the drug for < 1 month also take Humira, and have Gastroesophageal reflux disease.

The phase IV clinical study analyzes which people have Nasopharyngitis when taking Entocort ec. It is created by eHealthMe based on reports of 2,991 people who have side effects when taking Entocort ec from the FDA, and is updated regularly.

What is Entocort ec?

Entocort ec has active ingredients of budesonide. It is often used in crohn's disease. eHealthMe is studying from 3,232 Entocort ec users. Check the latest studies of Entocort ec.

What is Nasopharyngitis?

Nasopharyngitis (inflammation of the nasopharynx) is found to be associated with 2,440 drugs and 2,240 conditions by eHealthMe. Check the latest studies of Nasopharyngitis.

On Jul, 13, 2026

2,991 people reported to have side effects when taking Entocort ec.
Among them, 52 people (1.74%) have Nasopharyngitis.

Could Entocort ec cause Nasopharyngitis?

Among these 52 people:

How long have people been on Entocort ec when they have Nasopharyngitis? *

What is the gender of people who have Nasopharyngitis when taking Entocort ec? *

female: 67.31 %
male: 32.69 %

What is the age of people who have Nasopharyngitis when taking Entocort ec? *

What are other drugs people take besides Entocort ec? *

What are other side effects people have besides Nasopharyngitis? *

Cough: 13 people, 25.00%
Diarrhea: 9 people, 17.31%
Abdominal Pain: 8 people, 15.38%
Fatigue (feeling of tiredness): 7 people, 13.46%
Oropharyngeal Pain: 7 people, 13.46%
Rhinorrhea (watery mucus discharge from the nose): 6 people, 11.54%
Fever: 6 people, 11.54%
Pain: 5 people, 9.62%
Weight Decreased: 4 people, 7.69%
Abdominal Pain Upper: 4 people, 7.69%

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 7.69%
Asthma: 3 people, 5.77%
Depression: 3 people, 5.77%
Flatulence (flatus expelled through the anus): 3 people, 5.77%
Pain: 2 people, 3.85%
High Blood Pressure: 2 people, 3.85%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 2 people, 3.85%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 2 people, 3.85%
Uveitis (inflammation of the uvea): 1 person, 1.92%
Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 1 person, 1.92%

* Approximation only. Some reports may have incomplete information.

Do you take Entocort ec and have Nasopharyngitis?

- Check whether Nasopharyngitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Entocort ec:

Entocort ec (3,232 reports)

Nasopharyngitis treatments and more:

Nasopharyngitis (239,332 reports)

Browse all side effects of Entocort ec:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Nasopharyngitis:

Nasopharyngitis (2,440 drugs)

Browse all the conditions that are associated with Nasopharyngitis:

Nasopharyngitis (2,240 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on budesonide (the active ingredients of Entocort ec) and Entocort ec (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.